1. Home
  2. ARDX vs ETW Comparison

ARDX vs ETW Comparison

Compare ARDX & ETW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • ETW
  • Stock Information
  • Founded
  • ARDX 2007
  • ETW 2005
  • Country
  • ARDX United States
  • ETW United States
  • Employees
  • ARDX N/A
  • ETW N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • ETW Investment Managers
  • Sector
  • ARDX Health Care
  • ETW Finance
  • Exchange
  • ARDX Nasdaq
  • ETW Nasdaq
  • Market Cap
  • ARDX 882.9M
  • ETW 977.4M
  • IPO Year
  • ARDX 2014
  • ETW N/A
  • Fundamental
  • Price
  • ARDX $5.97
  • ETW $8.84
  • Analyst Decision
  • ARDX Strong Buy
  • ETW
  • Analyst Count
  • ARDX 9
  • ETW 0
  • Target Price
  • ARDX $10.50
  • ETW N/A
  • AVG Volume (30 Days)
  • ARDX 4.4M
  • ETW 284.6K
  • Earning Date
  • ARDX 08-04-2025
  • ETW 01-01-0001
  • Dividend Yield
  • ARDX N/A
  • ETW 8.61%
  • EPS Growth
  • ARDX N/A
  • ETW N/A
  • EPS
  • ARDX N/A
  • ETW N/A
  • Revenue
  • ARDX $386,146,000.00
  • ETW N/A
  • Revenue This Year
  • ARDX $10.10
  • ETW N/A
  • Revenue Next Year
  • ARDX $32.38
  • ETW N/A
  • P/E Ratio
  • ARDX N/A
  • ETW N/A
  • Revenue Growth
  • ARDX 83.88
  • ETW N/A
  • 52 Week Low
  • ARDX $3.21
  • ETW $6.96
  • 52 Week High
  • ARDX $7.18
  • ETW $8.49
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 82.99
  • ETW 56.01
  • Support Level
  • ARDX $4.08
  • ETW $8.88
  • Resistance Level
  • ARDX $5.31
  • ETW $9.02
  • Average True Range (ATR)
  • ARDX 0.24
  • ETW 0.07
  • MACD
  • ARDX 0.12
  • ETW 0.01
  • Stochastic Oscillator
  • ARDX 97.93
  • ETW 65.38

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About ETW Eaton Vance Corporation Eaton Vance Tax-Managed Global Buy-Write Opportunites Fund of Beneficial Interest

Eaton Vance Tax-mangd Glo Buy-write Oppo is a United States-based diversified, closed-end management investment company. The primary investment objective of the company is to provide current income and gains. The secondary objective of the fund is capital appreciation. The fund invests in a diversified portfolio of common stocks and writes call options on one or more U.S. indices on a substantial portion of the value of its common stock portfolio to generate current earnings from the option premium. Its portfolio of investments consists of capital markets, chemicals, banks, biotechnology, media, and other sectors.

Share on Social Networks: